We present a human immunodeficiency virus-infected patient with severe decompensated hepatitis C virus-related cirrhosis awaiting liver transplantation (LT) who received a 24-week course of interferon/ribavirin-free antiviral treatment with sofosbuvir and daclatasvir on a compassionate basis. Rapid viral suppression was associated with progressive improvement of his liver function tests. The patient achieved a sustained virological response and concomitant clinical improvement, which prompted removal from the LT list 12 weeks after the end of treatment.
Keywords: daclatasvir; hepatitis C virus; human immunodeficiency virus; sofosbuvir; transplant.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.